In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Replimune Group Inc (NASDAQ: REPL) closed at $5.33 in the last session, down -4.14% from day before closing price of $5.56. In other words, the price has decreased by -$4.14 from its previous closing price. On the day, 2.81 million shares were traded. REPL stock price reached its highest trading level at $5.4816 during the session, while it also had its lowest trading level at $5.18.
Ratios:
We take a closer look at REPL’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.94 and its Current Ratio is at 6.94. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
BMO Capital Markets Downgraded its Outperform to Underperform on July 23, 2025, while the target price for the stock was maintained at $2.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when Astley-Sparke Philip sold 32,279 shares for $8.06 per share. The transaction valued at 260,169 led to the insider holds 1,405,071 shares of the business.
Xynos Konstantinos sold 7,952 shares of REPL for $64,093 on May 20 ’25. The Chief Medical Officer now owns 146,933 shares after completing the transaction at $8.06 per share. On May 20 ’25, another insider, Schwendenman Andrew, who serves as the Chief Accounting Officer of the company, sold 3,287 shares for $8.05 each. As a result, the insider received 26,460 and left with 68,284 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REPL now has a Market Capitalization of 416037408 and an Enterprise Value of 89024656.
Stock Price History:
The Beta on a monthly basis for REPL is 0.51, which has changed by -0.49621928 over the last 52 weeks, in comparison to a change of 0.15222645 over the same period for the S&P500. Over the past 52 weeks, REPL has reached a high of $17.00, while it has fallen to a 52-week low of $2.68. The 50-Day Moving Average of the stock is -34.77%, while the 200-Day Moving Average is calculated to be -48.84%.
Shares Statistics:
According to the various share statistics, REPL traded on average about 8.92M shares per day over the past 3-months and 5223400 shares per day over the past 10 days. A total of 77.81M shares are outstanding, with a floating share count of 63.82M. Insiders hold about 18.23% of the company’s shares, while institutions hold 97.04% stake in the company. Shares short for REPL as of 1753920000 were 21308304 with a Short Ratio of 2.39, compared to 1751241600 on 9898243. Therefore, it implies a Short% of Shares Outstanding of 21308304 and a Short% of Float of 51.59.
Earnings Estimates
The stock of Replimune Group Inc (REPL) is currently being evaluated by 6.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.77, with high estimates of -$0.6 and low estimates of -$0.89.
Analysts are recommending an EPS of between -$2.85 and -$3.61 for the fiscal current year, implying an average EPS of -$3.14. EPS for the following year is -$1.82, with 5.0 analysts recommending between -$1.24 and -$2.22.
